201 related articles for article (PubMed ID: 27966015)
1. Oral shedding of human herpesviruses in patients undergoing radiotherapy/chemotherapy treatment for head and neck squamous cell carcinoma.
Palmieri M; Martins VAO; Sumita LM; Tozetto-Mendoza TR; Romano BB; Machado CM; Pannuti CS; Brandão TB; Ribeiro ACP; Corrêa L; Braz-Silva PH
Clin Oral Investig; 2017 Sep; 21(7):2291-2301. PubMed ID: 27966015
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of HSV-1/2 and correlation with aggravation of oral mucositis in patients with squamous cell carcinoma of the head and neck region submitted to antineoplastic treatment.
Correia AV; Coêlho MR; de Oliveira Mendes Cahú GG; de Almeida Silva JL; da Mota Vasconcelos Brasil C; de Castro JF
Support Care Cancer; 2015 Jul; 23(7):2105-11. PubMed ID: 25547479
[TBL] [Abstract][Full Text] [Related]
3. Oral shedding of human herpesviruses in patients undergoing radiotherapy/chemotherapy for head and neck squamous cell carcinoma is not affected by xerostomia.
Palmieri M; Ornaghi M; Martins VAO; Correa L; Brandao TB; Ribeiro ACDP; Sumita LM; Tozetto-Mendoza TR; Pannuti CS; Braz-Silva PH
J Oral Microbiol; 2018; 10(1):1476643. PubMed ID: 29868164
[No Abstract] [Full Text] [Related]
4. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
5. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
[TBL] [Abstract][Full Text] [Related]
6. Effect of granulocyte-macrophage colony-stimulating factor on prevention of mucositis in head and neck cancer patients treated with chemo-radiotherapy.
Rosso M; Blasi G; Gherlone E; Rosso R
J Chemother; 1997 Oct; 9(5):382-5. PubMed ID: 9373795
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of herpes virus associated with the presence and severity of oral mucositis in children diagnosed with acute lymphoid leukemia.
Santos de Faria AB; Silva IH; de Godoy Almeida R; Silva SP; Carvalho AT; Leão JC
J Oral Pathol Med; 2014 Apr; 43(4):298-303. PubMed ID: 24325331
[TBL] [Abstract][Full Text] [Related]
8. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy.
Chi KH; Chen CH; Chan WK; Chow KC; Chen SY; Yen SH; Chao JY; Chang CY; Chen KY
J Clin Oncol; 1995 Oct; 13(10):2620-8. PubMed ID: 7595716
[TBL] [Abstract][Full Text] [Related]
9. Can prophylactic application of immunoglobulin decrease radiotherapy-induced oral mucositis?
Mose S; Adamietz IA; Saran F; Thilmann C; Heyd R; Knecht R; Böttcher HD
Am J Clin Oncol; 1997 Aug; 20(4):407-11. PubMed ID: 9256900
[TBL] [Abstract][Full Text] [Related]
10. Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash.
Nicolatou-Galitis O; Dardoufas K; Markoulatos P; Sotiropoulou-Lontou A; Kyprianou K; Kolitsi G; Pissakas G; Skarleas C; Kouloulias V; Papanicolaou V; Legakis NJ; Velegraki A
J Oral Pathol Med; 2001 Sep; 30(8):471-80. PubMed ID: 11545238
[TBL] [Abstract][Full Text] [Related]
11. Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial.
Henke M; Alfonsi M; Foa P; Giralt J; Bardet E; Cerezo L; Salzwimmer M; Lizambri R; Emmerson L; Chen MG; Berger D
J Clin Oncol; 2011 Jul; 29(20):2815-20. PubMed ID: 21670447
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis with povidone-iodine against induction of oral mucositis by radiochemotherapy.
Adamietz IA; Rahn R; Böttcher HD; Schäfer V; Reimer K; Fleischer W
Support Care Cancer; 1998 Jul; 6(4):373-7. PubMed ID: 9695205
[TBL] [Abstract][Full Text] [Related]
13. [Management of oral mucositis in patients with head and neck cancer receiving chemoradiotherapy and/or molecular targeted therapy].
Zhang XX; Ma L; Wang JL; Wu WM; Feng LC; Huang DL
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jun; 46(6):505-8. PubMed ID: 21924104
[TBL] [Abstract][Full Text] [Related]
14. Relationship of protein and calorie intake to the severity of oral mucositis in patients with head and neck cancer receiving radiation therapy.
Zahn KL; Wong G; Bedrick EJ; Poston DG; Schroeder TM; Bauman JE
Head Neck; 2012 May; 34(5):655-62. PubMed ID: 21692134
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of radiochemotherapy-induced mucositis. Value of the prophylactic mouth rinsing with PVP-iodine solution].
Adamietz IA; Rahn R; Böttcher HD; Schäfer V; Reimer K; Fleischer W
Strahlenther Onkol; 1998 Mar; 174(3):149-55. PubMed ID: 9524624
[TBL] [Abstract][Full Text] [Related]
16. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
[TBL] [Abstract][Full Text] [Related]
17. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
18. Photobiomodulation with low-level laser therapy reduces oral mucositis caused by head and neck radio-chemotherapy: prospective randomized controlled trial.
Marín-Conde F; Castellanos-Cosano L; Pachón-Ibañez J; Serrera-Figallo MA; Gutiérrez-Pérez JL; Torres-Lagares D
Int J Oral Maxillofac Surg; 2019 Jul; 48(7):917-923. PubMed ID: 30591391
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
[TBL] [Abstract][Full Text] [Related]
20. Management of oral mucositis during local radiation and systemic chemotherapy: a study of 98 patients.
Carl W; Emrich LS
J Prosthet Dent; 1991 Sep; 66(3):361-9. PubMed ID: 1800734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
